-
BioLife Solutions Acquires Sexton Biotechnologies
contractpharma
August 10, 2021
Sexton supports cell and gene therapy manufacturing with two product lines; processing and handling solutions, and cell performance supplements.
-
Guidelines Updated for Treatment of Sexually Transmitted Infections
drugs
July 23, 2021
Guidelines for the treatment of people with or at risk for sexually transmitted infections (STIs) have been updated, according to a report published in the July 23 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly
-
Antikor forms alliance with Essex Bio-Investment for cancer treatment
pharmaceutical-technology
August 06, 2019
Antikor Biopharma has entered into a strategic alliance with Essex Bio-Technology’s wholly-owned subsidiary Essex Bio-Investment in Fragment-Drug Conjugates (FDC) for cancer treatment.
-
Testosterone May Rejuvenate Older Women's Sex Drive
drugs
July 26, 2019
Many older men take testosterone to boost their sex drive, but new research suggests that postmenopausal women who struggle with a sagging libido might want to follow suit.
-
Is Sex Good Medicine for Parkinson's?
drugs
July 16, 2019
Can sex help improve the health of a Parkinson's patient?
-
Awareness, Use of PrEP on Rise Among Men Who Have Sex With Men
drugs
July 12, 2019
Awareness, Use of PrEP on Rise Among Men Who Have Sex With Men.
-
Why Older Women Have Less Sex: It's Not as Simple as You Think
drugs
July 11, 2019
More than biology is at play when it comes to why older women have less sex as they age.
-
Sexual Activity May Cut Disability in Men With Early Parkinson Disease
drugs
July 09, 2019
Sexual Activity May Cut Disability in Men With Early Parkinson Disease.
-
FDA approves treatment for sexual dysfunction in premenopausal women
europeanpharmaceuticalreview
June 26, 2019
The FDA has announced its approval of a therapy for hypoactive sexual desire disorder in premenopausal women.
-
AMAG Pharmaceuticals Announces FDA Approval of Vyleesi (bremelanotide injection) for Hypoactive Sexual Desire Disorder (HSDD) in Premenopausal Women
drugs
June 24, 2019
AMAG Pharmaceuticals Announces FDA Approval of Vyleesi (bremelanotide injection) for Hypoactive Sexual Desire Disorder (HSDD) in Premenopausal Women.